Bitcoin, Biotech, and Biosteel: Innovation Powers the Opening Bell
DENVER, Colo., Sep 29, 2025 (247marketnews.com)- Wall Street kicks off the week with a multi-sector surge in momentum; from energy-efficient data mining in Michigan to courtroom victories in pharma and spider silk entering fashion runways. Investors have a wide array of catalysts to consider as Q4 approaches.
Hyperscale Data (NYSE:GPUS) is turning up the hash rate and the heat in Michigan with its announced upgrade to Bitmain Antminer S21+ Bitcoin miners, replacing the legacy S19J Pro models. The shift boosts each unit’s productivity by 135%, generating an estimated 2.35 BTC for every 1 BTC mined by the older fleet.
More than a mining upgrade, this move is part of a broader strategy: the company is developing its 617,000-square-foot Michigan Facility into a hybrid hub of Bitcoin mining and AI infrastructure, powered by NVIDIA hardware, including the upcoming Blackwell architecture.
“We are able to maximize efficiency, optimize asset utilization, and position the Michigan Facility for long-term growth,” said CEO William B. Horne.
Executive Chairman Milton “Todd” Ault III echoed the long-term commitment, calling the Michigan project the result of “years of planning and commitment to a strategy” that brings together the dual powerhouses of computing, AI and Bitcoin.
Importantly, GPUS will retain all mined Bitcoin, implementing its Digital Asset Treasury Strategy and issuing weekly updates on both holdings and dollar-cost averaging activity. This positions GPUS uniquely as both a data infrastructure play and a de facto Bitcoin treasury stock.
Kraig Biocraft Laboratories (OTCQB:KBLB) is catching momentum after completing its first dual-facility recombinant spider silk production cycle, a feat CEO Kim Thompson called a “transformative step.” The milestone marks a shift from R&D to scalable commercial viability.
Now, eyes turn to Q4, where fiber deliveries to a global fashion house and ongoing talks with sportswear brands may offer validation for a platform many had long considered technically unscalable. Traders are treating this as a potential proof-of-platform event.
RedHill Biopharma (NASDAQ:RDHL) scored a major win in the New York Supreme Court, which upheld a $10 million summary judgment in the company’s favor against Kukbo Co. Ltd. The court reaffirmed that RedHill had met its obligations, even after Kukbo breached its subscription and license agreements.
The award includes $8.25 million in damages plus $1.82 million in legal fees, alongside 9% statutory interest. The company also received a Korean court-ordered asset seizure, barring Kukbo from moving key assets ahead of judgment enforcement.
With legal clarity and financial compensation now firmly in its corner, RDHL may be poised to reallocate resources toward its pipeline with fresh confidence.
Plus Therapeutics (NASDAQ:PSTV) remains on investors’ radar after announcing that its subsidiary, CNSide Diagnostics, has signed a national coverage agreement with UnitedHealthcare Insurance (NYSE:UNH). The deal grants access to over 51 million Americans for its cerebrospinal fluid tumor cell enumeration test, a novel LDT (laboratory developed test).
This milestone could materially accelerate adoption of the CNSide platform, supporting Plus Therapeutics’ broader CNS-focused oncology roadmap.
Dragonfly Energy (NASDAQ:DFLI) is tacking on gains as management confirmed that the company is in talks with multiple commercial vehicle OEMs to integrate its solid-state lithium battery systems.
The appeal? Dragonfly’s “drop-in replacement” solution allows for electrification without reengineering legacy platforms, a major plus for fleet operators looking to electrify under budget and on deadline. With regulatory pressure on emissions mounting, DFLI’s retrofit-friendly platform is gaining serious industry traction.
PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated by one or more featured companies for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. Please go to https://247marketnews.com/kblb-disclosure/ for further KBLB and 247marketnews.com disclosure information.
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
CONTACT:
24/7 Market News
Editor@247marketnews.com